Merit Medical Systems, Inc. (MMSI)
Why Merit Medical (MMSI) is a Top Growth Stock for the Long-Term
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merit Medical (MMSI) is a Top-Ranked Momentum Stock: Should You Buy?
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Merit Medical Q2 Earnings Beat Estimates, Gross Margin Expands
MMSI beats second-quarter 2025 earnings estimates as gross margin expands and strong U.S. and Cardiovascular sales drive revenue growth.
Merit Medical (MMSI) Reports Q2 Earnings: What Key Metrics Have to Say
While the top- and bottom-line numbers for Merit Medical (MMSI) give a sense of how the business performed in the quarter ended June 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Will Merit Medical (MMSI) Beat Estimates Again in Its Next Earnings Report?
Merit Medical (MMSI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
MMSI Stock Gains Following Latest Merger to Boost Hemostasis Portfolio
Merit Medical aims to provide an additional effective solution that complements a wide range of percutaneous procedures, including interventional radiology and cardiology.
MMSI Stock Declines Despite Q1 Earnings Beating Estimates, Margins Up
Merit Medical benefits from revenue growth in both segments and the majority of its product categories within its Cardiovascular unit in the first quarter of 2025.
Merit Medical Systems, Inc. (MMSI) Q1 2025 Earnings Call Transcript
Merit Medical Systems, Inc. (NASDAQ:MMSI ) Q1 2025 Results Conference Call April 24, 2025 5:00 PM ET Company Participants Fred Lampropoulos - Founder, Chairman & Chief Executive Officer Raul Parra - Chief Financial Officer and Treasurer Brian Lloyd - Chief Legal Officer & Corporate Secretary Conference Call Participants Jason Bednar - Piper Sandler Steve Lichtman - Oppenheimer Robbie Marcus - J.P. Morgan Craig Bijou - Bank of America Securities David Rescott - Baird Michael Petusky - Barrington Research Jim Sidoti - Sidoti & Company Jon Young - Canaccord Mike Matson - Needham Jayson Bedford - Raymond James Operator Welcome to the Merit Medical Systems First Quarter 2025 Earnings Conference Call.
Compared to Estimates, Merit Medical (MMSI) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Merit Medical (MMSI) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Merit Medical (MMSI) Q1 Earnings and Revenues Top Estimates
Merit Medical (MMSI) came out with quarterly earnings of $0.86 per share, beating the Zacks Consensus Estimate of $0.75 per share. This compares to earnings of $0.77 per share a year ago.
What Analyst Projections for Key Metrics Reveal About Merit Medical (MMSI) Q1 Earnings
Beyond analysts' top -and-bottom-line estimates for Merit Medical (MMSI), evaluate projections for some of its key metrics to gain a better insight into how the business might have performed for the quarter ended March 2025.
Merit Medical (MMSI) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Merit Medical (MMSI) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
